Precise differentiation between jugular foramen paragangliomas and metastases: utility of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging
- PMID: 36635515
- DOI: 10.1007/s00234-023-03113-0
Precise differentiation between jugular foramen paragangliomas and metastases: utility of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging
Abstract
Purpose: This study tested the utility of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE-MRI) in differentiating paragangliomas and metastases in the jugular foramen in combination with conventional imaging.
Methods: Forty-nine consecutive patients with paragangliomas or metastases between January 2015 and April 2022 were included in this retrospective study. All patients had pretreatment DWI and DCE-MRI. Between paragangliomas and metastases, normalized apparent diffusion coefficient (nADCmean) and DCE-MRI parameters were compared along with conventional imaging features (enhancement pattern, presence of flow voids, cystic/necrotic change, and bone erosion). The diagnostic performance was tested using receiver operating characteristic (ROC) analysis.
Results: Thirty-five paragangliomas (5 male; median 49 years) and 14 metastases (9 male; median 61 years) were analyzed. The most common 3 primary cancers included 4 lung cancers, 3 breast cancers, and 3 melanomas. The presence of flow void was significantly different between paragangliomas and metastases (21/35 vs 2/14; P = 0.0047) in conventional imaging features, while fractional plasma volume (Vp) was significantly different between the two tumor types (median 0.46 vs 0.19; P < 0.001) in DWI and DCE-MRI parameters. The areas under the ROC curves (AUCs) of the presence of flow void and Vp were 0.72 and 0.93, respectively. The AUC of the combination of the presence of flow void and Vp was 0.95 and significantly improved compared to that of the presence of flow void (P < 0.001).
Conclusion: Adding DCE-MRI to the head and neck protocol can aid in the precise differentiation between jugular foramen paragangliomas and metastases.
Keywords: DCE-MRI; DWI; Jugular foramen; Metastasis; Paraganglioma.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
MR diffusion and dynamic-contrast enhanced imaging to distinguish meningioma, paraganglioma, and schwannoma in the cerebellopontine angle and jugular foramen.J Neuroimaging. 2022 May;32(3):502-510. doi: 10.1111/jon.12959. Epub 2021 Dec 22. J Neuroimaging. 2022. PMID: 34936708
-
Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma.Head Neck. 2021 Sep;43(9):2611-2622. doi: 10.1002/hed.26732. Epub 2021 May 3. Head Neck. 2021. PMID: 33938085
-
Advanced MRI to differentiate schwannomas and metastases in the cerebellopontine angle/internal auditory canal.J Neuroimaging. 2022 Nov;32(6):1177-1184. doi: 10.1111/jon.13028. Epub 2022 Jul 25. J Neuroimaging. 2022. PMID: 35879866 Free PMC article.
-
Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.Acta Radiol. 2021 Sep;62(9):1238-1247. doi: 10.1177/0284185120956269. Epub 2020 Sep 9. Acta Radiol. 2021. PMID: 32903025
-
How to do and evaluate DWI and DCE-MRI sequences for diabetic foot assessment.Skeletal Radiol. 2024 Oct;53(10):1979-1990. doi: 10.1007/s00256-023-04518-x. Epub 2023 Nov 25. Skeletal Radiol. 2024. PMID: 38001301 Review.
References
-
- Lowenheim H, Koerbel A, Ebner FH, Kumagami H, Ernemann U, Tatagiba M (2006) Differentiating imaging findings in primary and secondary tumors of the jugular foramen. Neurosurg Rev 29: 1–11; discussion 2–3
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous